Full Time Faculty

Scott W. Burchiel, Ph.D.
(505) 272-0920
Professor & Associate Dean for Research; Research Interests: Mechanisms of polycyclic aromatic hydrocarbon immunotoxicity and myelotoxicity, preclinical evaluation of biotechnology-derived products, rDNA‑derived cytokines.

Linda A. Felton, Ph.D.
(505) 272-2615
Associate Professor, Research interests: Adhesive and mechanical properties of polymeric drug delivery systems.

Changjian (Jim) Feng, Ph.D.
(505) 925-4326
Assistant Professor; Research Interests:  Mechanisms of regulation of nitric oxide synthase (NOS)

Donald Godwin, Ph.D.
(505) 272-2939
Associate Dean for Graduate and Professional Education and Associate Professor; Research Interests: Transdermal Drug Delivery, Transdermal penetration of environmental pollutants and toxicants (pesticides, heavy metals, etc.), toxicokinetics.

Laurie Hudson, Ph.D.
(505) 272-2484
Regents Professor; Research Interests: Keratinocyte growth and differentiation; retinoic acid receptor mediated pathways in cell biology.

Jim Liu , Ph.D.
(505) 272-9546
Professor; Research Interests: Free radical toxicology and measurement of free radicals in biological systems by ESR.

Renee-Claude Mercier, Pharm.D.
(505) 272-0581
Associate Professor; Research Interests: Pathogenesis of infective endocarditis as it pertains to the role of platelets in the development of endocarditis; antimicrobial activity of new anti-infective agents against multi-drug resistant bacteria.

Yubin Miao, PhD
(505) 925-4437
Assistant Professor; Research Interests: developing novel radiolabeled peptides for cancer diagnosis and therapy using radiolabeled alpha-melanocyte stimulating hormone (a-MSH) peptides for melanoma detection and therapy

Todd A. Thompson, Ph.D.
(505) 925-4710
Assistant Professor; Application of pharmacogenomic and toxicogenomic methods to assess chemopreventive and therapeutic strategies for cancer.

Graham Timmins Ph.D
(505) 272-4103
Associate Professor. Research interests: Melanoma Causation, Prevention & Detection; Roles of Drug-Derived Free Radicals in Tuberculosis Treatment.

Mary K. Walker, Ph.D.
(505) 272-0580
Professor; Research Interests: Developmental toxicology; molecular and cellular mechanisms of halogenated aromatic hydrocarbon teratogenicity; mechanisms leading to congenital heart malformations.

Part-Time Faculty, Research Interests

Melecita Archuleta, Ph.D.
(505) 845-9051
Clinical Assistant Professor; Research Interests: Evaluating toxicological data from SNL-deigned studies as well as from literature studies for hazards analysis, risk assessments and MSDS development.

Michael J. Barden, B.S.
(505) 821-5508
Clinical Assistant Professor
President and CEO of Geoscience Resources - A company that evaluates fate and transport of chemicals in soil and groundwater; environmental geochemistry; and conducts hazard assessments and risk assessments for contaminated water sites.

Ted Barrett, Ph.D.
(505) 348-9417
Clinical Assistant Professor; Research Interests: the contribution of cigarette smoke, ultrafine particles and maternal influence in asthma.

Steven A. Belinsky, Ph.D.
(505) 348-9465
Clinical Professor Research Interests: Proto-oncogene activation, tumor suppressor gene inactivation of during lung cancer development; 5-Methylcytosine methylation control of gene transcription and expression during tumor promotion.

Janet Benson, Ph.D., DABT
(505) 348-9457
Clinical Professor; Research Interests: the evaluation of the inhalation toxicity and toxicokinetics materials of occupational and environmental concern; mechanisms of metal-induced toxicity and carcinogenicity; the effects of ambient particles on airway resistance and cardiac function; the carcinogenicity of inhaled gasoline vapors; and the long-term health effects resulting from repeated exposure to red tide toxins.

Yung-Sung Cheng, Ph.D.
(505) 348-9410
Clinical Professor; Research Interests: Radon measurement; Aerosol deposition in the lung; Applied industrial hygiene; Asbestos fibers and respiratory protection

Larry Clevenger, MD, MPH
(505) 845-8037
Clinical Assistant Professor; Research interest include occupational diseases, exposure analysis and toxicological effects.

Donald C. Fisher, MD
(505) 275-7905
Clinical Assistant Professor; Research Interests: Occupational exposure of or workers to hazardous chemicals; Risk evaluation of new chemical products

Andrew Gigliotti, DVM, Ph.D., DACVP
(505) 348-9439
Clinical Assistant Professor; Research Interests: investigation of the role of the CCAAT/enhancer binding protein family of transcription factors in epithelial cell growth control; analysis of the in vivo effects of engine exhaust and other environmental pollutants; and examination of the correlation between in vivo and in vitro models and measures of respiratory disease.

Fletcher F. Hahn, Ph.D.
(505) 348-9428
Clinical Professor; Research Interests: Biological effects of inhaled environmental contaminants; Pathogenesis of morphologic changes in spontaneous and induced pulmonary diseases; Dose-response for early and late radiation effects

Kevin Harrod, Ph.D.
(505) 348-9488
Clinical Assistant Professor; Research Interests: transgenic and gene targeting strategies to elucidate the molecular mechanisms of host defense against acute respiratory infection.

Rogene F. Henderson, Ph.D.
(505) 845-1164
Clinical Professor; Research Interests: Biochemical mechanisms of lung injury; Fate of inhaled xenobiotics

James Hickman, Ph.D.
(505) 844-2113
Clinical Assistant Professor; Research Interests: investigating the first application of technologies to problems of national interest; information management and the application of IM techniques such as high speed massively parallel network search and data mining techniques to the identification, location and response to emerging diseases.

Charles H. Hobbs, DVM
(505) 348-9413
Clinical Professor; Research Interests: Long-term inhalation studies; Late effects of inhaled materials

Joe L. Mauderly, DVM
(505) 348-9432
Clinical Professor; Research Interests: Respiratory Pathophysiology; Carcinogenesis from inhaled particles and associated organic compounds

Jacob D. McDonald, Ph.D.
(505) 348-9455
Clinical Assistant Professor; Research Interests: physical and chemical characterization of exposure atmospheres used for laboratory health studies, and their relationship to ‘real world’ atmospheric compositions; the relationship between mixtures of environmental pollutants and public health.

Matthew Reed, Ph.D.
(505) 348-9451
Clinical Assistant Professor; Research Interests: the implications of the interaction of quinoid compounds with cellular macromolecules; identification of biochemical mechanisms associated with low-level PAH-quinone/quinone mixture induction of toxicity and cellular proliferation in lung epithelium.

Robert Rubin, Ph.D.
(505) 348-9367
Clinical Professor; President and CEO of Lovelace Respiratory Research Institute, a non-profit organization specializing in respiratory toxicology research.

Bobby Scott, Ph.D.
(505) 348-9470
Clinical Associate Professor; Research Interests: the development of models for predicting deterministic and stochastic health effects of ionizing radiation, and the use of models for health risk assessment; computational research addressing, via Bayesian methods, the integration of dosimetry, cell killing, mutagenesis, and neoplastic transformation induced by radiation.

JeanClare Seagrave, Ph.D.
(505) 348-9499
Clinical Assistant Professor; Research Interests: Signal transduction particularly the mechanisms by which extra cellular signals affect calcium pathways. Examining the effects of particulate material including cigarette smoke on the functions of lung epithelial and immune cells.

Mohan Sopori, Ph.D.
(505) 348-9440
Clinical Associate Professor; Research Interests: Effects of cigarette smoke on the immune system

Yohannes Tesfaigzi, Ph.D.
(505) 348-9495
Clinical Associate Professor; Research Interests: Patients who suffer from chronic bronchitis, chronic obstructive pulmonary disease, or asthma have persistent mucous cell hyperplasia and increased mucus secretion resulting in airway obstruction. Suppressing expression of Bcl-2, an inhibitor of apoptosis, using antisense oligonucleotides, which may lead to a reduction of the number of mucous cells in the airways of these patients. Identifying the inflammatory components, which may induce Bax, a pro-apoptotic protein, instead of Bcl-2 using an in vitro organ culture system. The cell cycle-specific function of a small proline-rich protein that was isolated from squamous differentiating tracheal epithelial cells.